M. Vachon

Effect of formulation excipients and the manufacturing process for solid dosage form on the initial dissolution of theophylline

M. Viana, E. Caramigeas, M. Vachon, 2000 .

The use of 13C solid state NMR to elucidate physico-chemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acid.

M. Vachon, J. Nairn, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The influence of microencapsulation using Eudragit RS100 on the hydrolysis kinetics of acetylsalicylic acid.

M. Vachon, J. Nairn, M. G. Vachon, 1997, Journal of microencapsulation.

Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS100 microspheres prepared using a solvent-partition method.

M. Vachon, J. Nairn, M. G. Vachon, 1995, Journal of microencapsulation.

A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.

D. Fordyce, M. Vachon, P. Guivarc'h, 2004, Clinical therapeutics.

Enthalpy—entropy compensation in pharmaceutical solids

D. Grant, M. Vachon, 1987 .